FDA
-
-
-
-
-
-
-
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
-
-
-
-
-
-
-
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
-
-
-
-
-
-
-
Piper Sandler: 'What Biotech Names to Own in Market Volatility'
-
-
-
-
-
-
-
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
-
-
-
-
-
-
-
The Galien Foundation Announces 2024 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases"
-
329,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

